NIT
SAGE

NumerixS Investment Technologies’s Sage Therapeutics SAGE Stock Holding History

NumerixS Investment Technologies’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,400
Closed -$40K – 1268
2020
Q1 		$40K Buy
+1,400
New +$81.1K 0.02% 664
2018
Q4 		– Sell
-4,300
Closed -$594K – 1334
2018
Q3 		$594K Buy
+4,300
New +$664K 0.11% 256
2018
Q1 		– Sell
-800
Closed -$132K – 1249
2017
Q4 		$132K Buy
+800
New +$77.6K 0.03% 593
2017
Q2 		– Sell
-700
Closed -$50K – 1320
2017
Q1 		$50K Buy
+700
New +$41K 0.01% 1017

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return